Literature DB >> 26956810

Fluorescein Sodium-Guided Surgery of Malignant Brain Tumors: History, Current Concepts, and Future Project.

Karl-Michael Schebesch1, Alexander Brawanski, Christoph Hohenberger, Julius Hohne.   

Abstract

Fluorescein sodium (FL)-guided resection has become an important and beneficial treatment method for malignant brain tumors. FL-guided resection improves the rate of gross total resection in high-grade gliomas (HGG) and cerebral metastases (CM). FL sensitively visualizes the disruption of the blood-brain barrier in the area surrounding malignant lesions, similar to contrast-enhanced T1-weighted MR sequences. This review of the current literature summarizes the history of FL in neurosurgery from 1946 until today. We discuss the molecular mechanism of FL accumulation in cerebral malignant tumors and provide an overview of the current practice of using FL and applying a dedicated surgical microscope filter. Additionally, we outline and discuss ongoing trials and future projects.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26956810     DOI: 10.5137/1019-5149.JTN.16952-16.0

Source DB:  PubMed          Journal:  Turk Neurosurg        ISSN: 1019-5149            Impact factor:   1.003


  16 in total

1.  Fluorescein-Guided Surgery for Pediatric Brainstem Gliomas: Preliminary Study and Technical Notes.

Authors:  Zhan Xue; Lu Kong; Chang-Cun Pan; Zhen Wu; Jun-Ting Zhang; Li-Wei Zhang
Journal:  J Neurol Surg B Skull Base       Date:  2018-06-25

2.  Quantification of ALA-fluorescence induced by a modified commercially available head lamp and a surgical microscope.

Authors:  Michael Sabel; Johannes Knipps; Lisa Margarete Neumann; Max Kieslich; Hans-Jakob Steiger; Marion Rapp; Marcel A Kamp
Journal:  Neurosurg Rev       Date:  2018-07-23       Impact factor: 3.042

3.  On the use of fluorescein-based contrast agents as analogs to MRI-gadolinium agents for imaging brain tumors.

Authors:  Scott C Davis; Margaret R Folaron; Rendall R Strawbridge; Caroline Filan; Kimberley S Samkoe; David W Roberts
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2019-03-07

4.  Elucidating the kinetics of sodium fluorescein for fluorescence-guided surgery of glioma.

Authors:  Margaret Folaron; Rendall Strawbridge; Kimberley S Samkoe; Caroline Filan; David W Roberts; Scott C Davis
Journal:  J Neurosurg       Date:  2018-09-07       Impact factor: 5.115

Review 5.  Surgical Considerations in the Optimal Management of Patients with Malignant Brain Tumors.

Authors:  Jaclyn J Renfrow; Roy E Strowd; Adrian W Laxton; Stephen B Tatter; Carol P Geer; Glenn J Lesser
Journal:  Curr Treat Options Oncol       Date:  2017-08

Review 6.  The utilization of sodium fluorescein in pediatric brain stem gliomas: a case report and review of the literature.

Authors:  Cameron M Erdman; Catherine Christie; M Omar Iqbal; Catherine A Mazzola; Luke Tomycz
Journal:  Childs Nerv Syst       Date:  2020-08-11       Impact factor: 1.475

7.  Second-Window Indocyanine Green for Visualization of Hemangioblastoma: A Case Report With Two-Dimensional Operative Video.

Authors:  Yash B Singh; Steve S Cho; Rachel Blue; Clare W Teng; Emma De Ravin; Love Buch; John Y K Lee
Journal:  Oper Neurosurg (Hagerstown)       Date:  2021-02-16       Impact factor: 2.703

Review 8.  Fluorescence-Guided Surgery: A Review on Timing and Use in Brain Tumor Surgery.

Authors:  Alexander J Schupper; Manasa Rao; Nicki Mohammadi; Rebecca Baron; John Y K Lee; Francesco Acerbi; Constantinos G Hadjipanayis
Journal:  Front Neurol       Date:  2021-06-16       Impact factor: 4.003

9.  Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance.

Authors:  Wei Wu; Jessica L Klockow; Michael Zhang; Famyrah Lafortune; Edwin Chang; Linchun Jin; Yang Wu; Heike E Daldrup-Link
Journal:  Pharmacol Res       Date:  2021-07-21       Impact factor: 10.334

10.  Optical Characterization of Sodium Fluorescein In Vitro and Ex Vivo.

Authors:  Ran Xu; Wanda Teich; Florian Frenzel; Katrin Hoffmann; Josefine Radke; Judith Rösler; Katharina Faust; Anne Blank; Susan Brandenburg; Martin Misch; Peter Vajkoczy; Julia Sophie Onken; Ute Resch-Genger
Journal:  Front Oncol       Date:  2021-05-10       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.